NVS-ZP7-4

N/A

Report date: 2023/03/06 09:58:00
NME

Base Information

Drug NameNVS-ZP7-4
Drug Alias NameNVS-ZP-7-4NVS-ZP7-4
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionZinc transporter SLC39A7 inhibitors
TargetsZinc transporter SLC39A7
Therapy Area/IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesNovartis Pharma Ag
Inactive CompaniesN/A
Active IndicationsPrecursor T-Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A